Literature DB >> 27746619

Tackling the Hepatitis C Disease Burden in Punjab, India.

Radha K Dhiman1, Sandeep Satsangi1, Gagandeep S Grover2, Pankaj Puri3.   

Abstract

Hepatitis C virus (HCV) is a globally prevalent pathogen and is a major cause of healthcare burden in India. HCV poses a significant problem in the state of Punjab, India owing to the higher prevalence of risk factors like unsafe medical practices (including unsafe injections and dental procedures) and intravenous drug use. The reported prevalence of HCV in this part of the country was 5.2% in 2012, while a recent study has shown the prevalence to be 3.2% in 2016. Similar to the other geographic belts in India, genotype 3 predominates in the state of Punjab. Control of HCV infection in Punjab requires focusing on several strategies. There is a need to formulate a health educational curriculum targeting not only the high-risk population but also the general population regarding the transmission of HCV. Training of family physicians who form the first link to patients in the community is imperative in the success of healthcare programmes. Adopting the dual approach of treating the old cases (decreasing the reservoir pool of HCV) and decreasing the incidence of new ones would help curtail the disease and decrease liver related mortality. A commendable initiative has been launched by the Punjab state government to eliminate HCV from Punjab. However, besides the initiative by the government, a concerted effort by all other stakeholders in managing the HCV burden in India, namely the doctors, the drug companies and the non-government organizations is required for control of HCV.

Entities:  

Keywords:  BPL, below poverty line; DNDi, drugs for neglected diseases initiative; ECHO, Extension for Community Healthcare Outcomes; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HCW, health care worker; HD, hemodialysis; INASL, Indian National Association for study of the Liver; IVDU, intravenous drug user; MMPHCRF, Mukh Mantri Punjab Hepatitis-C Relief Fund; NAT, nucleic acid testing; NGO, non-government organization; PSACS, Punjab State AIDS Control Society; Punjab; control; hepatitis C; prevalence

Year:  2016        PMID: 27746619      PMCID: PMC5052426          DOI: 10.1016/j.jceh.2016.09.005

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  41 in total

1.  Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.

Authors:  V Saraswat; S Norris; R J de Knegt; J F Sanchez Avila; M Sonderup; E Zuckerman; P Arkkila; C Stedman; S Acharya; I Aho; A C Anand; M I Andersson; V Arendt; O Baatarkhuu; K Barclay; Z Ben-Ari; C Bergin; F Bessone; S Blach; N Blokhina; C R Brunton; G Choudhuri; V Chulanov; L Cisneros; E A Croes; Y A Dahgwahdorj; O Dalgard; J R Daruich; N R Dashdorj; D Davaadorj; M de Vree; C Estes; R Flisiak; A C Gadano; E Gane; W Halota; A Hatzakis; C Henderson; P Hoffmann; J Hornell; D Houlihan; S Hrusovsky; P Jarčuška; D Kershenobich; K Kostrzewska; P Kristian; M Leshno; Y Lurie; A Mahomed; N Mamonova; N Mendez-Sanchez; J Mossong; E Nurmukhametova; P Nymadawa; M Oltman; J Oyunbileg; Ts Oyunsuren; G Papatheodoridis; N Pimenov; N Prabdial-Sing; M Prins; P Puri; S Radke; A Rakhmanova; H Razavi; K Razavi-Shearer; H W Reesink; E Ridruejo; R Safadi; O Sagalova; R Sanduijav; I Schréter; C Seguin-Devaux; S R Shah; I Shestakova; A Shevaldin; O Shibolet; S Sokolov; K Souliotis; C W Spearman; T Staub; E A Strebkova; D Struck; K Tomasiewicz; L Undram; A J van der Meer; D van Santen; I Veldhuijzen; F G Villamil; S Willemse; F R Zuure; M O Silva; V Sypsa; E Gower
Journal:  J Viral Hepat       Date:  2015-01       Impact factor: 3.728

Review 2.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

3.  Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.

Authors:  Samiran Panda; Tarun Roy; Sobha Pahari; Jyotiee Mehraa; Neeraj Sharma; Gagandeep Singh; Jasbir Singh; Francis Joseph; Sukhvinder Singh; Narinder M Sharma
Journal:  Int J STD AIDS       Date:  2013-12-18       Impact factor: 1.359

Review 4.  Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.

Authors:  Norah Palmateer; Jo Kimber; Matthew Hickman; Sharon Hutchinson; Tim Rhodes; David Goldberg
Journal:  Addiction       Date:  2010-03-02       Impact factor: 6.526

5.  Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India.

Authors:  Sukanya Raghuraman; R V Shaji; Gopalan Sridharan; Sujatha Radhakrishnan; George Chandy; B S Ramakrishna; Priya Abraham
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

6.  Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based survey.

Authors:  Ajit Sood; Shiv Kumar Sarin; Vandana Midha; Syed Hissar; Neena Sood; Pankaj Bansal; Manu Bansal
Journal:  Indian J Gastroenterol       Date:  2012-10-17

7.  Prevalence, risk factors and genotype distribution of HCV and HBV infection in the tribal population: a community based study in south India.

Authors:  Madhavi Chandra; M N Khaja; Nafeesa Farees; C D Poduri; M M Hussain; M Aejaz Habeeb; C M Habibullah
Journal:  Trop Gastroenterol       Date:  2003 Oct-Dec

8.  Estimating the Burden of Disease from Unsafe Injections in India: A Cost-benefit Assessment of the Auto-disable Syringe in a Country with Low Blood-borne Virus Prevalence.

Authors:  Savanna Reid
Journal:  Indian J Community Med       Date:  2012-04

9.  Frequency distribution of Hepatitis C virus in different geographical regions of Punjab: Retrospective study from a tertiary care centre in North India.

Authors:  Paramdeep Singh; Rupinderjeet Kaur; Amarpreet Kaur
Journal:  J Nat Sci Biol Med       Date:  2014-01

Review 10.  Hepatitis C virus and vaccine development.

Authors:  Malihe Naderi; Naghmeh Gholipour; Mohammad Reza Zolfaghari; Maryam Moradi Binabaj; Ahmad Yegane Moghadam; Gholamreza Motalleb
Journal:  Int J Mol Cell Med       Date:  2014
View more
  15 in total

Review 1.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

2.  Direct-Acting Antiviral Agents for HCV Infection.

Authors:  Madhumita Premkumar; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2018-03-26

Review 3.  Hepatitis C elimination: a Public Health Perspective.

Authors:  Radha K Dhiman; Gagandeep S Grover; Madhumita Premkumar
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

4.  Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.

Authors:  Eshan U Patel; Sunil S Solomon; Allison M Mcfall; Aylur K Srikrishnan; Amrose Pradeep; Paneerselvam Nandagopal; Oliver Laeyendecker; Aaron A R Tobian; David L Thomas; Mark S Sulkowski; M Suresh Kumar; Shruti H Mehta
Journal:  Int J Drug Policy       Date:  2018-04-19

5.  Epidemiology of hepatitis C virus infection in a tertiary care hospital.

Authors:  Atul Kumar Sood; Manish Manrai; Sandeep Thareja; Rajat Shukla; Amol Patel
Journal:  Med J Armed Forces India       Date:  2019-12-11

Review 6.  Epidemiology of Liver Diseases in India.

Authors:  Dipankar Mondal; Kausik Das; Abhijit Chowdhury
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-01-28

7.  Hepatitis B Prevalence and Risk Factors in Punjab, India: A Population-Based Serosurvey.

Authors:  Shaun Shadaker; Ajit Sood; Francisco Averhoff; Anil Suryaprasad; Subodh Kanchi; Vandana Midha; Saleem Kamili; Muazzam Nasrullah; Adam Trickey; Ravinder Garg; Pramod Mittal; Suresh K Sharma; Peter Vickerman; Paige A Armstrong
Journal:  J Clin Exp Hepatol       Date:  2022-04-18

Review 8.  Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?

Authors:  Madhumita Premkumar; Gagandeep S Grover; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2017-09-23

9.  Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.

Authors:  Partha S Mukherjee; Sreenivas Vishnubhatla; Deepak N Amarapurkar; Kausik Das; Ajit Sood; Yogesh K Chawla; Chundamannil E Eapen; Prabhakar Boddu; Varghese Thomas; Subodh Varshney; Diamond Sharma Hidangmayum; Pradip Bhaumik; Bhaskar Thakur; Subrat K Acharya; Abhijit Chowdhury
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

10.  The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey.

Authors:  Ajit Sood; A Suryaprasad; A Trickey; S Kanchi; V Midha; M A Foster; E Bennett; S Kamili; F Alvarez-Bognar; S Shadaker; V Surlikar; R Garg; P Mittal; S Sharma; M T May; P Vickerman; F Averhoff
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.